Cargando…
Novel Lipid-Lowering Agents Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors: Do They Show Mortality Benefits?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082012/ https://www.ncbi.nlm.nih.gov/pubmed/30123740 http://dx.doi.org/10.4103/ijabmr.IJABMR_217_18 |
| _version_ | 1783345748089241600 |
|---|---|
| author | Mahajan, Rajiv |
| author_facet | Mahajan, Rajiv |
| author_sort | Mahajan, Rajiv |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6082012 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60820122018-08-17 Novel Lipid-Lowering Agents Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors: Do They Show Mortality Benefits? Mahajan, Rajiv Int J Appl Basic Med Res Editorial Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6082012/ /pubmed/30123740 http://dx.doi.org/10.4103/ijabmr.IJABMR_217_18 Text en Copyright: © 2018 International Journal of Applied and Basic Medical Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Editorial Mahajan, Rajiv Novel Lipid-Lowering Agents Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors: Do They Show Mortality Benefits? |
| title | Novel Lipid-Lowering Agents Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors: Do They Show Mortality Benefits? |
| title_full | Novel Lipid-Lowering Agents Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors: Do They Show Mortality Benefits? |
| title_fullStr | Novel Lipid-Lowering Agents Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors: Do They Show Mortality Benefits? |
| title_full_unstemmed | Novel Lipid-Lowering Agents Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors: Do They Show Mortality Benefits? |
| title_short | Novel Lipid-Lowering Agents Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors: Do They Show Mortality Benefits? |
| title_sort | novel lipid-lowering agents proprotein convertase subtilisin-kexin type 9 inhibitors: do they show mortality benefits? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082012/ https://www.ncbi.nlm.nih.gov/pubmed/30123740 http://dx.doi.org/10.4103/ijabmr.IJABMR_217_18 |
| work_keys_str_mv | AT mahajanrajiv novellipidloweringagentsproproteinconvertasesubtilisinkexintype9inhibitorsdotheyshowmortalitybenefits |